Immunology and Microbiology
Chronic Fatigue Syndrome
100%
Allele
61%
Mycobacterium Tuberculosis
47%
Human Herpesvirus 6
46%
Human Leukocyte Antigen
34%
Blood Plasma
32%
Tumor Necrosis Factor
32%
Microbiome
32%
Prevalence
31%
Tick-Borne Encephalitis
27%
COVID-19
27%
Whole Genome Sequencing
25%
Myelopid
25%
Viral Load
23%
Microflora
22%
Legionella
21%
Seroprevalence
21%
Zoonotic
21%
Human Herpesvirus 7
20%
Ulcerative Colitis
20%
Cytokine
19%
Single Nucleotide Polymorphism
18%
Human Parvovirus B19
18%
Otitis Media
18%
Legionella pneumophila
18%
Echinococcosis
18%
Measles
18%
Pseudomonas aeruginosa
18%
Autoimmunity
18%
Middle Ear
18%
C-Reactive Protein
18%
Antimicrobial Resistance
18%
Interleukin 10
18%
ELISA
17%
Infectious Agent
17%
Haplotype
16%
Autoimmune Disease
16%
Hepatitis C
15%
HLA DRB1 Antigen
15%
Genetic Polymorphism
15%
Blood Level
15%
Herpesviridae
14%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Interleukin 6
14%
Hepatitis C Virus
13%
Tick Borne Encephalitis Virus
13%
Genetic Distance
13%
Drug Sensitivity
13%
Human Immunodeficiency Virus 1
13%
Diphtheria Antibody
13%
Gene Sequence
13%
Central Nervous System
13%
Drug Resistance
12%
Interferon Gamma
12%
Cell Death
12%
Seropositivity
12%
Human Immunoglobulin
12%
Lineages
11%
Gene Frequency
11%
Bacteriophage
11%
Immunoglobulin M Antibody
10%
Immunoglobulin G4
10%
Enzyme-Linked Immunosorbent Assay
9%
Microorganism
9%
Polymerase Chain Reaction
9%
Hepatitis A Virus
9%
Measles Antibody
9%
Feces microflora
9%
Inflammatory Bowel Disease
9%
Enterobacteriaceae
9%
Intercellular Adhesion Molecule 1
9%
HLA-DQ
9%
HLA-DR
9%
Wart Virus
9%
Lung Ventilation
9%
Scleroderma
9%
Oxidative Stress
9%
Macrophage Migration Inhibition Factor
9%
Fas Ligand
9%
DNA Conformation
9%
Veillonella
9%
Gastrointestinal Mucosa
9%
Paraffin Embedding
9%
Resistome
9%
Systemic Scleroderma
9%
Promoter Region
9%
Lipid Peroxidation
9%
Immunoreactivity
9%
Roseolovirus
9%
Monkeypox Virus
9%
Toxoplasma gondii
9%
Multiple Sclerosis
9%
Upper Respiratory Tract
9%
Allergen
9%
Gram-Negative Bacteria
9%
Chromatography
9%
Absorption
9%
Intestine Flora
9%
Dirofilaria repens
9%
Programmed Cell Death
9%
Medicine and Dentistry
Pneumococcal Infection
45%
COVID-19
42%
Tick Borne Encephalitis
39%
Hepatitis C
39%
Serotype
38%
Prevalence
37%
Actinic Keratosis
36%
Hepatitis C Virus
34%
Brain Ischemia
33%
Apoplexy
31%
Bleeding
27%
Sepsis
27%
Plasminogen Activator Inhibitor-1
27%
Cross Sectional Study
26%
Outpatient
25%
Microbiome
25%
Mycobacterium Tuberculosis
25%
Differential Diagnosis
22%
Lyme Borreliosis
21%
Allele
21%
Clinical Feature
20%
Enteropathy
19%
Cerebral Hemorrhage
19%
Liver Fibrosis
18%
Oxidative Stress
18%
Chronic Fatigue Syndrome
18%
Heart Surgery
18%
Polyneuropathy
18%
RNA 16S
18%
Transient Ischemic Attack
18%
Wart Virus
18%
Ulcerative Colitis
18%
Gut Microbiome
18%
Antibiotic Resistance
18%
Biological Marker
18%
Pneumococcus
17%
Odds Ratio
17%
Computer Assisted Tomography
17%
Liver Cirrhosis
17%
Comorbidity
15%
Troponin T
14%
Liver Graft
14%
Whole Genome Sequencing
13%
Tick Borne Encephalitis Virus
13%
Intestinal Permeability
13%
Bacteriophage
13%
Human Immunodeficiency Virus
13%
Streptococcus Pneumonia
13%
Pneumococcal Pneumonia
13%
Disease Course
13%
Miliary Tuberculosis
13%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Anemia
12%
Human Immunodeficiency Virus 1 Infection
12%
Medical Record
12%
Magnetic Resonance Imaging
12%
Autoimmune Disease
11%
Antioxidant
11%
Lung
11%
Glomerular Filtration Rate
11%
Dizziness
11%
Gene Frequency
11%
Headache
11%
Central Nervous System
11%
Combination Therapy
10%
Gastroenterology
10%
Chronic Hepatitis C
10%
Alcohol Liver Disease
10%
Mild Cognitive Impairment
10%
HLA-DRB1
10%
Iron Deficiency
10%
Cognitive Defect
10%
Cardiopulmonary Bypass
10%
Necrosis
10%
Gut
10%
Mortality Rate
10%
Meningoencephalitis
10%
Mixed Infection
10%
Observational Study
10%
Enzyme Linked Immunosorbent Assay
9%
Chronic Kidney Disease
9%
National Institutes of Health Stroke Scale
9%
Tick Bite
9%
Papillomavirus Infection
9%
Hepatitis Virus
9%
Group Trial
9%
Multidrug Resistant Tuberculosis
9%
Hepatitis C Virus Genotype 1
9%
Ombitasvir
9%
Ribavirin
9%
Dasabuvir
9%
Ritonavir
9%
ECG Abnormality
9%
Enterobacteriaceae
9%
Myasthenia gravis
9%
Hypochromic Anemia
9%
Paritaprevir
9%
Scleroderma
9%
Peritonitis
9%
Liver Injury
9%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C
61%
Prevalence
54%
Brain Ischemia
47%
Sepsis
38%
Hepatitis C Virus
38%
Ulcerative Colitis
36%
Antimicrobial Resistance
35%
Mycobacterium Tuberculosis
31%
Colistimethate
29%
Lung Tuberculosis
28%
Fibrinolytic Agent
27%
Actinic Keratosis
27%
C Reactive Protein
27%
Pneumococcal Infection
27%
Vancomycin
26%
Therapeutic Drug Monitoring
22%
Comorbidity
22%
Tuberculostatic Agent
21%
Rifampicin
20%
Elimination
19%
Cerebrovascular Accident
18%
Virus Hepatitis
18%
Troponin T
18%
Liver Injury
18%
Microflora
18%
Liver Fibrosis
18%
Tick Borne Encephalitis
18%
Transient Ischemic Attack
18%
Plasminogen Activator Inhibitor 1
18%
Tumor Necrosis Factor
18%
Biological Marker
16%
Liver Cirrhosis
16%
Inflammation
16%
Mortality Rate
14%
SARS Coronavirus
13%
Squamous Cell Carcinoma
13%
HLA DRB1 Antigen
13%
Intestinal Permeability
13%
HIV
13%
Human Immunodeficiency Virus Infection
13%
Miliary Tuberculosis
13%
Enteropathy
12%
Disease Course
12%
Ethambutol
12%
Retrospective Study
12%
Necrosis
12%
Clinical Feature
12%
Bleeding
12%
Brain Hemorrhage
12%
Enzyme-Linked Immunosorbent Assay
12%
Cross-Sectional Study
12%
Focused Ion Beam
11%
Microbiome
11%
Antiinfective Agent
11%
Creatinine
11%
Case Fatality Rate
10%
Coronavirinae
10%
Lactate Dehydrogenase
10%
Interleukin 6
10%
Inflammatory Bowel Disease
9%
Atrial Fibrillation
9%
Combination Therapy
9%
Meningoencephalitis
9%
Chronic Fatigue Syndrome
9%
Syndrome
9%
Diphtheria
9%
Measles
9%
ECG Abnormality
9%
Sudden Death
9%
Dabigatran
9%
Penicillinase
9%
Bowen's Disease
9%
Cyclin D
9%
Toxic Hepatitis
9%
Brain Hematoma
9%
Hepatitis A Virus
9%
Pathogen Clearance
9%
Chronic Obstructive Lung Disease
9%
Dipeptidyl Carboxypeptidase
9%
Angiogenic Factor
9%
Wet Macular Degeneration
9%
Fas Ligand
9%
Macrophage Migration Inhibition Factor
9%
Mixed Infection
9%
Myasthenia gravis
9%
Human Immunoglobulin
9%
Adult Respiratory Distress Syndrome
9%
Idarucizumab
9%
Antithrombotic Therapy
9%
Streptomycin
9%
Pseudomonas aeruginosa
9%
Legionella
9%
Amoeba (Life Cycle Stage)
9%
Gram Negative Bacterium
9%
Genetic Predisposition
9%
Multi-Drug-Resistant Tuberculosis
9%
Liver Abscess
9%
Enterococcus
9%
Tick Borne Encephalitis Virus
9%
Cross Sectional Study
9%